Insufficient scRNA-seq data for expression of SP140 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 467.13 | 578 / 578 | 88% | 4.05 | 1020 / 1155 |
breast | 79% | 90.74 | 364 / 459 | 76% | 3.18 | 854 / 1118 |
stomach | 73% | 93.85 | 261 / 359 | 66% | 2.77 | 189 / 286 |
thymus | 82% | 176.04 | 533 / 653 | 47% | 1.93 | 286 / 605 |
intestine | 70% | 567.24 | 678 / 966 | 59% | 2.55 | 309 / 527 |
uterus | 63% | 45.43 | 107 / 170 | 63% | 2.42 | 287 / 459 |
bladder | 67% | 100.05 | 14 / 21 | 56% | 2.34 | 284 / 504 |
brain | 67% | 59.23 | 1776 / 2642 | 54% | 1.28 | 383 / 705 |
kidney | 60% | 109.08 | 53 / 89 | 61% | 1.89 | 551 / 901 |
skin | 56% | 45.89 | 1010 / 1809 | 63% | 4.10 | 296 / 472 |
ovary | 71% | 52.82 | 128 / 180 | 47% | 1.03 | 202 / 430 |
prostate | 79% | 99.35 | 194 / 245 | 29% | 0.72 | 146 / 502 |
esophagus | 43% | 46.04 | 621 / 1445 | 62% | 2.26 | 113 / 183 |
liver | 63% | 52.23 | 142 / 226 | 38% | 1.37 | 153 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 75.80 | 29 / 29 |
spleen | 100% | 3381.47 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2252.05 | 928 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 77% | 60.11 | 198 / 258 | 13% | 0.32 | 29 / 230 |
tonsil | 0% | 0 | 0 / 0 | 89% | 5.42 | 40 / 45 |
pancreas | 8% | 5.07 | 26 / 328 | 80% | 3.87 | 142 / 178 |
adipose | 85% | 123.42 | 1023 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 42% | 59.43 | 561 / 1335 | 0% | 0 | 0 / 0 |
heart | 33% | 26.98 | 286 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 0.38 | 11 / 80 |
muscle | 1% | 1.00 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006952 | Biological process | defense response |
GO_0001650 | Cellular component | fibrillar center |
GO_0016605 | Cellular component | PML body |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | SP140 |
Protein name | Nuclear body protein SP140 (Lymphoid-restricted homolog of Sp100) (LYSp100) (Nuclear autoantigen Sp-140) (Speckled 140 kDa) SP140 protein SP140 nuclear body protein |
Synonyms | LYSP100 |
Description | FUNCTION: Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body . May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection . May play a role in chromatin-mediated regulation of gene expression although it does not bind to histone H3 tails . . |
Accessions | ENST00000343805.10 [Q13342-6] ENST00000417495.7 [Q13342-3] ENST00000456542.5 U3KPV9 ENST00000420434.7 [Q13342-5] ENST00000392045.8 [Q13342-1] ENST00000373645.3 [Q13342-4] Q13342 Q0VGE4 Q7Z2U4 |